GT Biopharma (GTBP) had the highest return between May 5, 2012 and January 4, 2013 by a US stock, returning 1,560,599,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 5/5/2012 - 1/4/2013 | 1,560,599,900% |
OLB (OLB) | 5/5/2012 - 1/4/2013 | 11,190.32% |
Par Pacific (PARR) | 5/5/2012 - 1/4/2013 | 1,816.67% |
Actinium Pharmaceuticals (ATNM) | 5/5/2012 - 1/4/2013 | 1,400% |
Vivakor (VIVK) | 5/5/2012 - 1/4/2013 | 1,166.15% |
Sarepta Therapeutics (SRPT) | 5/5/2012 - 1/4/2013 | 475.4% |
Security National Financial (SNFCA) | 5/5/2012 - 1/4/2013 | 470.5% |
TOMI Environmental Solutions (TOMZ) | 5/5/2012 - 1/4/2013 | 400% |
BOS Better Online Solutions (BOSC) | 5/5/2012 - 1/4/2013 | 389.53% |
Astrana Health (ASTH) | 5/5/2012 - 1/4/2013 | 369% |
Imunon (IMNN) | 5/5/2012 - 1/4/2013 | 322.63% |
BioLife Solutions (BLFS) | 5/5/2012 - 1/4/2013 | 312.5% |
BTCS (BTCS) | 5/5/2012 - 1/4/2013 | 310% |
Hovnanian Enterprises (HOV) | 5/5/2012 - 1/4/2013 | 308.88% |
COSCIENS Biopharma (CSCI) | 5/5/2012 - 1/4/2013 | 308.2% |
MiMedx (MDXG) | 5/5/2012 - 1/4/2013 | 278.9% |
Milestone Scientific (MLSS) | 5/5/2012 - 1/4/2013 | 266.67% |
Helport AI Limited Ordinary Shares (HPAI) | 5/5/2012 - 1/4/2013 | 257.14% |
Avita Medical (RCEL) | 5/5/2012 - 1/4/2013 | 257.03% |
AlphaTON Capital (ATON) | 5/5/2012 - 1/4/2013 | 244.83% |
Portage Biotech (PRTG) | 5/5/2012 - 1/4/2013 | 244.83% |
ACADIA Pharmaceuticals (ACAD) | 5/5/2012 - 1/4/2013 | 230% |
Harrow Health (HROW) | 5/5/2012 - 1/4/2013 | 224.07% |
Consumer Portfolio Services (CPSS) | 5/5/2012 - 1/4/2013 | 207.82% |
Fennec Pharmaceuticals (FENC) | 5/5/2012 - 1/4/2013 | 207.6% |
